Top compounds associated with response to DLX2


Feature Type Standardized
Nominal ANOVA
mRNA cediranib CTRPv2 pan-cancer AAC 0.29 7e-08
mRNA Axitinib CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.18 7e-07
mRNA alisertib CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA AC220 GDSC1000 pan-cancer AAC 0.16 3e-06
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.14 6e-06
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.14 9e-06
mRNA vincristine CTRPv2 pan-cancer AAC 0.13 1e-05
mRNA chlorambucil CTRPv2 pan-cancer AAC 0.13 1e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.13 2e-05
Download CSV